Evidence map›Paper›PMID 33039988›Full record

ArticleBMJ open2020

Can children swallow tablets? Outcome data from a feasibility study to assess the acceptability of different-sized placebo tablets in children (creating acceptable tablets (CAT)).

Louise Bracken, Emma McDonough, Samantha Ashleigh, Fiona Wilson, Joanne Shakeshaft, Udeme Ohia, Punam Mistry, Huw Jones, Nazim Kanji, Fang Liu and 1 more

Abstract read
In one paragraph

Article in BMJ open, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed.

  1. Article
  2. If a Child Vomits After an Oral Medication-Should We Re-Dose or Not?Acta paediatrica (Oslo, Norway : 1992) · 2025
    Review
  3. Antiretroviral medications for pediatric use in the context of the Unified Health System: are there therapeutic gaps in Brazil?Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2025
    Article
  4. Observational
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Louise BrackenPaediatric Medicines Research Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.ORCID 0000-0002-9632-2252
Emma McDonoughPaediatric Medicines Research Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Samantha AshleighNIHR Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Fiona WilsonNIHR Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Joanne ShakeshaftPaediatric Medicines Research Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Udeme OhiaNIHR Alder Hey Clinical Research Facility, Alder Hey Children's NHS Foundation Trust, Liverpool, UK.
Punam MistryCancer Research UK Clinical Trials Unit, Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK.
Huw JonesPediatric Services, Quotient Sciences, Nottingham, UK.
Nazim KanjiPediatric Services, Quotient Sciences, Nottingham, UK.
Fang LiuDepartment of Clinical and Pharmaceutical Sciences, University of Hertfordshire, Hatfield, UK.
Matthew PeakPaediatric Medicines Research Unit, Alder Hey Children's NHS Foundation Trust, Liverpool, UK Matthew.Peak@alderhey.nhs.uk.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveFeasibility study to investigate the acceptability of different-sized placebo tablets in children aged 4-12 years. DESIGN AND

settingClinical Research Facilities, inpatient wards and outpatient clinics within a Regional Paediatric Hospital and/or District General Hospital. Healthy children and National Health Service (NHS) patients were asked to swallow three placebo tablets: 6 mm, 8 mm and 10 mm, smallest to largest. The researcher observed children's facial expressions and behaviours on swallowing and measured the volume of water consumed. Participants completed a questionnaire about the overall acceptability; including swallowability, taste and volume of water consumed. For analysis, participants were stratified by age: 4-8 years and 9-12 years.

resultsThe feasibility study led to an estimated recruitment rate of 0.8% for NHS inpatients and 211 healthy children over a 1-year period. In total, 55 participants were recruited, 30 to the younger group, of which 77% had never taken a tablet before. 84% of the 25 older children had previously taken a tablet. All participants attempted to swallow the smallest sized tablet. The children aged 4-8 years found the larger tablets easier to swallow, however the older children found little difference between the tablet sizes. The younger children required more water to swallow each tablet size compared with the older children where an increasing volume of water was consumed as tablet size increased. Taste was rated highly for both age groups. The 8 mm tablets were deemed the most acceptable tablet size by all participants.

conclusionTablets are potentially an acceptable formulation for children aged 4-12 years. Most children aged 4-8 years who attempted to swallow tablets successfully did so. Recruitment of NHS inpatients to medicine acceptability studies is challenging, however, recruitment of children of staff proved an effective strategy. Valuable lessons have been learnt from this feasibility study which will inform the design of a larger definitive trial.

Indexed as

DeglutitionState MedicineAdolescentChildFeasibility StudiesHumansTabletsTasteTabletsoral medicinepaediatricstherapeutics

Identifiers

PMID33039988
PMCPMC7549447

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.